SARS-CoV-2 Variants and Vaccines.

Philip R KrauseThomas R FlemingIra M LonginiRichard PetoSylvie BriandDavid L HeymannValerie BeralMatthew D SnapeHelen ReesAlba-Maria RoperoRan D BalicerJakob P CramerCésar Muñoz-FontelaMarion GruberRogerio GasparJerome A SinghKanta SubbaraoMaria D Van KerkhoveSoumya SwaminathanMichael J RyanAna-Maria Henao-Restrepo

Published in: The New England journal of medicine (2021)

Viral variants of concern may emerge with dangerous resistance to the immunity generated by the current vaccines to prevent coronavirus disease 2019 (Covid-19). Moreover, if some variants of concern have increased transmissibility or virulence, the importance of efficient public health measures and vaccination programs will increase. The global response must be both timely and science based.

Keyphrases

sars cov
public health
coronavirus disease
copy number
respiratory syndrome coronavirus
escherichia coli
pseudomonas aeruginosa
cystic fibrosis
antimicrobial resistance
biofilm formation